查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012525

吻合器市场：按技术、手术类型、材料、分销管道、应用和最终用途划分－2026-2032年全球市场预测

Anastomosis Devices Market by Technology, Procedure Type, Material Type, Distribution Channel, Application, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，吻合器市值将达到 32.5 亿美元，到 2026 年将成长至 34.8 亿美元，到 2032 年将达到 57.1 亿美元，复合年增长率为 8.38%。

主要市场统计数据
基准年 2025 32.5亿美元
预计年份：2026年 34.8亿美元
预测年份 2032 57.1亿美元
复合年增长率 (%) 8.38%

对现代吻合器市场进行全面概述，重点在于医疗保健系统的临床驱动因素、创新方向和采购重点。

吻合器械产业正处于一个十字路口，临床上对改善手术效果的需求与器械层面的快速创新相互交织。本报告首先概述了当前的市场格局，外科医生、医院管理者和器械製造商都在努力应对日益复杂的临床、监管和商业性因素。随着器械人体工学、生物相容性材料和手术专用工具的不断改进，相关人员正在修订采购计画和产品蓝图，以反映不断变化的临床偏好和手术流程。

对重塑吻合器市场竞争优势和采用趋势的技术、临床和监管变化进行详细分析。

吻合器材市场正经历一场变革性的转型，其驱动因素包括技术进步、临床实务以及供应链韧性。在技​​术层面，电动器材和智慧型装置介面正在提升复杂吻合术的精准度和一致性。同时，生物可降解材料和复合材料的进步正在增强组织整合，并减少长期异物反应。这些技术变革并非孤立存在，而是正在影响培训计画、手术流程和器械维护模式，因此需要采取全面性的商业化策略。

对 2025 年美国新关税政策将如何影响设备供应链中的製造地、分销策略和采购趋势进行了深入分析。

美国将于2025年实施新的关税措施，将进一步增加医疗设备製造商和医疗保健系统采购商的供应链和定价策略的复杂性。关税调整正在影响各个分销管道的采购决策，迫使企业重新评估製造地，并影响供应商和医疗保健采购商之间的谈判。为此，许多製造商正在探索近岸外包、区域组装基地和采购多元化等策略，以缓解成本压力，同时保持品管和前置作业时间的可靠性。

基于细分市场的详细洞察，揭示了影响需求的临床适应症、最终用途环境、技术类型、治疗方法、分销管道和材料选择。

市场区隔提供了一个分析框架，用于理解创新与需求在临床和商业性层面的交会点。基于应用领域，市场研究涵盖心血管和消化器官系统外科领域，其中心血管领域进一步细分为冠状动脉和血管，消化器官系统则细分为结直肠、食道和胃。这种结构突显了临床适应症如何决定医疗设备的设计重点，例如管腔尺寸相容性、加强策略和止血控制。基于最终用户，市场调查涵盖门诊手术中心、医院和专科诊所等不同场所，揭示了受病例组成、资金预算和无菌资源等因素驱动的不同采购行为。

从战略区域观点审视美洲、欧洲、中东和非洲以及亚太地区不同的医疗保健系统，每个系统都需要量身定制的商业化策略和监管策略。

区域趋势是产品开发、监管策略和商业部署策略规划的核心。在美洲，医疗保健系统由先进的三级医疗机构和社区医院组成，采购决策受到对整合式医疗网络、报销模式和打包支付结果的重视。在这种环境下，拥有可靠的临床核准和可扩展培训计画的系统更具优势。在欧洲、中东和非洲，监管环境的差异以及医院采购结构的多样性促使製造商采取量身定制的打入市场策略，以平衡集中审批和本地伙伴关係。同时，特定市场的成本敏感度也推动了模组化产品和灵活商业模式的发展。

权威概述了竞争趋势，展示了吻合解决方案的市场领导地位是如何由平台策略、临床证据产生和策略伙伴关係关係决定的。

吻合器材领域的竞争动态由成熟的医疗设备製造商和灵活创新的专业公司共同塑造。主要企业致力于开发涵盖器械、耗材和手术培训的整合平台，并与外科团队和医院系统建立牢固的合作关係。这些公司正透过多中心研究和上市后註册研究来累积临床证据，以证明其产品性能优于同类产品，并为医保报销提供依据。同时，小规模、专注于技术的新兴参与企业则凭藉其独特的材料科学和自动化能力，致力于解决特定的临床难题，开拓利基应用领域。

为医疗设备製造商提供切实可行的策略建议，以协调创新、临床证据和稳健的经营模式，确保在所有医疗保健环境中可持续应用。

产业领导企业应优先考虑整合产品创新与临床工作流程、供应链韧性和实证医学证据的整合方法。投资于电动设备平台和直觉的使用者介面，既能降低手术结果的差异性，又能使产品在医院和门诊环境中脱颖而出。同时，丰富材料组合，纳入可生物降解材料和复合材料选项，可以满足临床医生不同的偏好和长期安全性的担忧。重要的是，製造商应建立临床项目，产生可靠的真实世界数据和外科医生主导的证据，以促进产品推广应用并支持与保险公司的对话。

采用高度透明的调查方法，结合定性专家访谈、监管和临床文献审查以及情境分析，以检验策略结论和建议。

本研究结合了对外科专家、采购经理和医疗设备工程师的定性访谈，以及对监管申报文件、临床文献和医疗机构公开采购惯例的二次分析。调查方法强调跨资料来源的三角验证，以确保研究结果既反映临床实际情况，也考虑商业性限制。主要研究内容包括：透过结构化访谈了解医疗专业人员的偏好；对采购和培训项目进行案例研究分析；以及对医疗设备设计和材料进行技术审查，以评估性能权衡。

结论强调，循证创新、供应链韧性和一体化商业化对于实现可持续的临床和商业性成功至关重要。

总之，吻合器材领域的特点是临床创新、材料科学进步和不断变化的商业性压力之间存在着动态的互动关係。在这个市场取得成功，需要兼顾两方面：一是提供可重复的手术性能，二是建构稳健的、基于实证医学的商业模式，以适应不断变化的区域法规和经济状况。将动力器材、多样化的材料选择和全面的临床培训项目整合到一致的价值提案的利益相关人员，将更有能力满足临床医生的需求和医疗机构的采购标准。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：吻合器市场：依技术划分

  • 手动输入
  • 电的

第九章：吻合器市场：依手术类型划分

  • 微创
  • 开放性手术

第十章 吻合器市场：依材料分类

  • 可生物降解
  • 复合材料
  • 钛

第十一章 吻合器市场：依通路划分

  • 直销
  • 线上销售
  • 第三方经销商

第十二章 吻合器市场：依应用领域划分

  • 心血管系统
    • 冠状动脉
    • 血管
  • 消化器官系统
    • 大肠和直肠
    • 食道
    • 胃

第十三章 吻合器市场：依最终用途划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十四章 吻合器市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 吻合器市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 吻合器市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 美国：吻合器材市场

第十八章 中国：吻合器械市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AtriCure, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • ConMed Corporation
  • Cook Medical LLC
  • Getinge AB
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Peters Surgical Company, Inc.
  • Smiths Group plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-431F213C91D8

The Anastomosis Devices Market was valued at USD 3.25 billion in 2025 and is projected to grow to USD 3.48 billion in 2026, with a CAGR of 8.38%, reaching USD 5.71 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.25 billion
Estimated Year [2026] USD 3.48 billion
Forecast Year [2032] USD 5.71 billion
CAGR (%) 8.38%

Comprehensive introduction to the contemporary anastomosis devices landscape highlighting clinical drivers, innovation vectors, and procurement priorities for healthcare systems

The anastomosis devices sector stands at an inflection point as clinical demand for improved surgical outcomes converges with rapid device-level innovation. This report opens by framing the contemporary landscape in which surgeons, hospital administrators, and device manufacturers navigate an increasingly complex set of clinical, regulatory, and commercial considerations. Building on sustained improvements in instrument ergonomics, tissue-compatible materials, and procedure-specific tooling, stakeholders are recalibrating procurement and product road maps to reflect evolving clinical preferences and procedural workflows.

As minimally invasive techniques become standard of care across a widening range of cardiovascular and gastrointestinal procedures, device developers are responding with systems that emphasize reproducibility, reduced operative time, and enhanced tissue healing. Concurrently, payers and health systems are placing greater emphasis on value-based outcomes. Consequently, manufacturers must demonstrate not only technical performance but also integration with care pathways, training programs, and inventory management. This introduction establishes the core themes examined throughout the report and orients readers to the major drivers shaping near-term clinical adoption and commercial competition.

Detailed analysis of the technological, clinical, and regulatory shifts reshaping competitive advantage and adoption dynamics in the anastomosis devices market

The anastomosis devices landscape is undergoing transformative shifts driven by convergent forces in technology, clinical practice, and supply chain resilience. On the technology front, powered instrumentation and intelligent device interfaces are improving precision and consistency across complex anastomoses, while advances in biodegradable and composite materials are enhancing tissue integration and reducing long-term foreign body reactions. These technological shifts are not isolated; they influence training programs, procedural protocols, and device servicing models, necessitating a holistic approach to commercialization.

Clinically, surgeons are increasingly favoring techniques that minimize tissue trauma and shorten recovery, which has catalyzed broader adoption of minimally invasive approaches. As hospitals and ambulatory surgical centers refine perioperative pathways to optimize throughput and patient experience, device suppliers must align product development with the evolving cadence of care. Meanwhile, regulatory scrutiny and greater emphasis on post-market surveillance are elevating quality assurance and evidence-generation as commercial imperatives. Taken together, these trends are reshaping competitive advantage, where differentiation increasingly depends on a combination of clinical evidence, integrated services, and adaptable distribution models.

Insightful examination of how new United States tariff policies for 2025 are influencing manufacturing footprints, distribution strategies, and procurement dynamics in device supply chains

The introduction of new tariff measures in the United States for 2025 has introduced an added layer of complexity to supply chain and pricing strategies for device manufacturers and health system purchasers. Tariff adjustments influence procurement decisions across distribution channels, compel reassessment of manufacturing footprints, and shape negotiations between suppliers and institutional buyers. In response, many manufacturers are examining near-shoring, regional assembly hubs, and diversified sourcing to mitigate cost pressure while maintaining quality controls and lead-time reliability.

Beyond direct cost implications, tariffs can affect channel dynamics by altering the relative competitiveness of direct sales versus third-party distribution, and by incentivizing digital and online sales channels that reduce middle-tier costs. Healthcare providers are evaluating total cost of ownership with greater scrutiny, factoring in logistics risk, expected device longevity tied to material selection, and potential regulatory compliance costs. In short, tariff-driven shifts are reinforcing the importance of supply chain agility and contractual flexibility as central components of commercial strategy in the anastomosis devices sector.

In-depth segmentation-driven insights revealing clinical indications, end-use environments, technology types, procedure approaches, distribution channels, and material choices shaping demand

Segmentation provides the analytical framework to understand where innovation and demand converge across clinical and commercial axes. Based on application, the market is studied across cardiovascular and gastrointestinal procedures, with cardiovascular further divided into coronary and vascular, and gastrointestinal split into colorectal, esophageal, and gastric; this structure highlights how clinical indications drive device design priorities such as lumen size compatibility, reinforcement strategies, and hemostasis control. Based on end use, the market is studied across ambulatory surgical center, hospitals, and specialty clinic settings, revealing divergent procurement behaviors driven by case mix, capital budgets, and sterilization resources.

Drawing on technology segmentation, the market is studied across manual and powered solutions, enabling differential assessments of usability, training burden, and procedure time impacts. Based on procedure type, the market is studied across minimally invasive and open surgery approaches, which clarifies adoption trajectories as minimally invasive techniques continue to displace traditional open procedures for many indications. Based on distribution channel, the market is studied across direct sales, online sales, and third party distributors, which surfaces channel economics, service expectations, and aftermarket support requirements. Lastly, based on material type, the market is studied across biodegradable, composite, and titanium options to capture trade-offs between tissue compatibility, mechanical integrity, and long-term implant behavior. Together, these segmentations illuminate where clinical needs, reimbursement dynamics, and operational realities intersect to create pockets of opportunity and competitive pressure.

Strategic regional perspective on how diverse healthcare systems across the Americas, Europe Middle East & Africa, and Asia-Pacific require tailored commercialization tactics and regulatory strategies

Regional dynamics are central to strategic planning for product development, regulatory strategy, and commercial deployment. In the Americas, healthcare systems display a mix of advanced tertiary centers and community hospitals where purchasing decisions are influenced by integrated care networks, reimbursement models, and emphasis on bundled payment outcomes; this environment favors systems with robust clinical evidence and scalable training programs. In Europe, Middle East & Africa, regulatory heterogeneity and varying hospital procurement structures lead manufacturers to pursue tailored market entry strategies that balance centralized approvals with local partnerships, while cost-sensitivity in certain markets encourages modular product offerings and flexible commercial models.

Asia-Pacific markets present a diverse set of growth and adoption patterns driven by rising surgical capacity, expansion of minimally invasive programs, and government-led healthcare investments. Suppliers engaging these markets often combine localized manufacturing or assembly with collaborative training and clinical education initiatives to accelerate adoption. Across all regions, differences in supply chain resilience, tariff exposure, and distribution ecosystems require companies to adopt region-specific playbooks that integrate regulatory foresight, strategic partnerships, and adaptable pricing structures to succeed in a fragmented global landscape.

Authoritative overview of competitive dynamics showing how platform strategies, clinical evidence generation, and strategic partnerships determine market leadership in anastomosis solutions

Competitive dynamics in the anastomosis devices space are shaped by a mix of established medical device firms and agile specialized innovators. Leading companies are focusing on platform development that integrates instrumentation, consumables, and procedural training to create sticky relationships with surgical teams and hospital systems. These firms are investing in clinical evidence generation, often through multi-center studies and post-market registries, to demonstrate comparative performance and to support reimbursement discussions. At the same time, smaller, technology-focused entrants are pursuing niche applications with unique material science or automation features that address specific clinical pain points.

Partnerships and strategic alliances are increasingly common, enabling larger organizations to augment product portfolios with targeted technologies while providing scale and distribution reach. Concurrently, OEM and contract manufacturers are evolving from pure production partners into co-development collaborators, offering expertise in device engineering, regulatory navigation, and cost optimization. The overall competitive environment rewards companies that can combine clinical credibility with operational excellence in manufacturing, supply chain, and customer support.

Actionable strategic recommendations for device makers to align innovation, clinical evidence, and resilient commercial models to secure durable adoption across care settings

Industry leaders should prioritize an integrated approach that aligns product innovation with clinical workflows, supply chain resilience, and evidence generation. Investing in powered device platforms and intuitive user interfaces can reduce variance in surgical outcomes while differentiating offerings in hospital and ambulatory settings. In parallel, diversifying material portfolios to include biodegradable and composite options will address clinician preference variability and long-term safety considerations. Importantly, manufacturers should structure clinical programs that generate robust real-world data and surgeon-led evidence to support adoption and payer dialogue.

From an operational perspective, firms must reassess sourcing strategies to mitigate tariff exposure and logistics risk, including options for regional assembly and strategic vendor diversification. Commercially, tailoring distribution strategies to the needs of hospitals, ambulatory surgical centers, and specialty clinics will improve market penetration; this can include hybrid models combining direct specialist sales with online ordering options for high-turn consumables. Finally, investing in comprehensive training, proctoring, and value-based contracting will strengthen provider relationships and embed devices within care pathways, creating durable advantages in a competitive landscape.

Transparent research methodology combining qualitative expert interviews, regulatory and clinical literature review, and scenario analysis to validate strategic conclusions and recommendations

This study synthesizes primary qualitative interviews with surgical specialists, procurement leaders, and device engineers alongside secondary analysis of regulatory filings, clinical literature, and publicly available institutional procurement practices. The methodology emphasizes triangulation across data sources to ensure findings reflect both clinical realities and commercial constraints. Key inputs include structured interviews to surface practitioner preferences, case study analysis of procurement and training programs, and technical reviews of device designs and materials to assess performance trade-offs.

Analytical techniques incorporate comparative scenario analysis to evaluate impacts of tariff changes and distribution strategies, as well as segmentation mapping to identify high-priority application and end-use clusters. Quality assurance processes included source validation and expert review panels to corroborate interpretations and to refine recommended actions. This approach produces insights that are actionable for product development, go-to-market planning, and organizational design without relying on proprietary market sizing.

Concluding synthesis emphasizing the imperative for evidence-backed innovation, supply chain resilience, and integrated commercialization to achieve sustained clinical and commercial success

In conclusion, the anastomosis devices sector is characterized by dynamic interplay between clinical innovation, material science advances, and shifting commercial pressures. Success in this market requires a dual focus on delivering reproducible surgical performance and on building resilient, evidence-backed commercial models that can adapt to regional regulatory and economic variability. Stakeholders that integrate powered instrumentation, versatile material options, and strong clinical training programs into a coherent value proposition will be best positioned to meet clinician needs and institutional purchasing criteria.

Moving forward, companies should maintain agility in supply chain planning and prioritize partnerships that accelerate clinical acceptance. By aligning product road maps with the procedural trends toward minimally invasive care and by investing in the real-world evidence that buyers demand, manufacturers and investors can create sustainable competitive differentiation and support improved patient outcomes across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anastomosis Devices Market, by Technology

  • 8.1. Manual
  • 8.2. Powered

9. Anastomosis Devices Market, by Procedure Type

  • 9.1. Minimally Invasive
  • 9.2. Open Surgery

10. Anastomosis Devices Market, by Material Type

  • 10.1. Biodegradable
  • 10.2. Composite
  • 10.3. Titanium

11. Anastomosis Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Sales
  • 11.3. Third Party Distributors

12. Anastomosis Devices Market, by Application

  • 12.1. Cardiovascular
    • 12.1.1. Coronary
    • 12.1.2. Vascular
  • 12.2. Gastrointestinal
    • 12.2.1. Colorectal
    • 12.2.2. Esophageal
    • 12.2.3. Gastric

13. Anastomosis Devices Market, by End Use

  • 13.1. Ambulatory Surgical Center
  • 13.2. Hospitals
  • 13.3. Specialty Clinic

14. Anastomosis Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Anastomosis Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Anastomosis Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Anastomosis Devices Market

18. China Anastomosis Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AtriCure, Inc.
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International Inc.
  • 19.8. Becton, Dickinson and Company
  • 19.9. Boston Scientific Corporation
  • 19.10. Cardinal Health, Inc.
  • 19.11. ConMed Corporation
  • 19.12. Cook Medical LLC
  • 19.13. Getinge AB
  • 19.14. Intuitive Surgical, Inc.
  • 19.15. Johnson & Johnson
  • 19.16. LivaNova PLC
  • 19.17. Medtronic plc
  • 19.18. Meril Life Sciences Pvt. Ltd.
  • 19.19. Peters Surgical Company, Inc.
  • 19.20. Smiths Group plc
  • 19.21. Stryker Corporation
  • 19.22. Teleflex Incorporated
  • 19.23. Terumo Corporation
  • 19.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GASTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 160. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 161. GCC ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 187. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 188. G7 ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 196. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 197. NATO ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA ANASTOMOSIS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA ANASTOMOSIS DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)